The Cancer Institute NSW Premier's Awards for Outstanding Cancer Research are the premier awards ceremony for the cancer research sector in NSW. Now in its tenth year, the event honours the achievements of the individuals and teams that work across the cancer research sector to lessen the impact of cancer for the people of NSW.
These awards are an opportunity to honour the state's outstanding cancer researchers whose brilliant minds together with their commitment to years and even decades of focused work have led to new discoveries about cancer diagnoses, treatments and survival. Their achievements reflect that improving cancer outcomes is a series of incremental steps.
As the NSW Government's cancer control agency, the Cancer Institute NSW supports, facilitates and collaborates with all in the cancer control sector to translate new discoveries in to meaningful knowledge to improve the health system of NSW. This new information is providing the evidence we need to drive rapid improvement in cancer prevention, treatment, care and ultimately, survival outcomes.
Dean Ho is a Provost's Chair Professor in the Departments of Biomedical Engineering and Pharmacology, Director of the N.1 Institute for Health, and Head of the Department of Biomedical Engineering at the National University of Singapore. He was previously a professor at UCLA, and associate professor in the Departments of Biomedical Engineering and Mechanical Engineering in the Robert R. McCormick School of Engineering and Applied Science, and Full Member of the Robert H. Lurie Comprehensive Cancer Center at the Feinberg School of Medicine of Northwestern University, Illinois, United States.
The Melanoma Institute Australia is a non-profit organization based at the Poche Centre in North Sydney, Australia which focuses on prevention of and cure for melanoma through research, treatment and education programs. The institute is affiliated with The University of Sydney and St Vincent’s and Mater Health Sydney. It relies on funding from individuals, organisations and government grants.
Pamela J. Russell was an Australian academic researcher of immunology, bladder and prostate research. Russell was awarded Membership of the Order of Australia (AM) for her research on prostate and bladder cancer in 2003.
Michelle Haber is an Australian cancer researcher.
Judith Ann Clements is an Australian academic and educator, specializing in Kallikrein proteases in prostate and ovarian cancers. Clements is the scientific director at the Australian Prostate Cancer Research Centre – Queensland and was head of the Cancer Research Program at the Institute of Health and Biomedical Innovation (IHBI) of Queensland University of Technology at the Translational Research Institute (Australia) from 1997–2014.
Consuelo H. Wilkins is an American physician, biomedical researcher, and health equity expert. She is Senior Vice President and Senior Associate Dean for Health Equity and Inclusive Excellence at Vanderbilt University Medical Center. She is a professor of medicine in the Department of Medicine, Division of Geriatrics at Vanderbilt University School of Medicine and has a joint appointment at Meharry Medical College. She additionally serves as one of the principal investigators of the Vanderbilt Clinical and Translational Science Award, Director of the Meharry-Vanderbilt Community Engaged Research Core (CTSA) and as vice president for Health Equity at Vanderbilt University Medical Center.
Alan Stuart Coates is an Australian professor of clinical oncology, medical researcher and administrator. He was the inaugural CEO of the Cancer Council Australia (1998–2006), former president of the Clinical Oncological Society of Australia (COSA), and co-chair of the St. Gallen International Breast Cancer Conference. He was also the first non-American to be elected to the board of directors of the American Society of Clinical Oncology.
J. William Harbour, M.D., is an American ophthalmologist, ocular oncologist and cancer researcher. He is currently Chair of the Department of Ophthalmology at the University of Texas Southwestern Medical Center in Dallas. He previously served as the vice chair and director of ocular oncology at the Bascom Palmer Eye Institute and associate director for basic science at the Sylvester Comprehensive Cancer Center of the University of Miami's Miller School of Medicine.
Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.
Anthony J Gill is an Australian pathologist, professor of surgical pathology at the University of Sydney and the chairman of the Australian Pancreatic Cancer Genome Initiative - part of the International Cancer Genome Consortium. Most of his research is focused on translating the improved understanding of cancer gained at the basic science level into clinically useful diagnostic tests which can be applied in the routine surgical pathology laboratory.
Richard Anthony Scolyer is an Australian pathologist. He is a senior staff specialist in tissue pathology and diagnostic oncology at Royal Prince Alfred Hospital, co-medical director at the Melanoma Institute Australia, and Cojoint professor at the University of Sydney.
Minoti Vivek Apte is an Indian-born Australian pancreatology researcher and is the Director of Pancreatic Research Group at the University of South Wales and Ingham Institute for Applied Medical Research in Liverpool, New South Wales, Australia. She is also a classical Indian dancer and choreographer. Apte is notable for her many achievements in the field of pancreatic disease research, including becoming the first in the world to successfully isolate pancreatic stellate cells (PSCs), the cells associated with pancreatic fibrogenesis. The effectiveness of this isolation method allowed her team to prove that PSCs’ close communication with cancerous cells contributes to the aggressiveness of pancreatic cancer, a major discovery that led the government of New South Wales to award her The Premier's Award for Woman of the Year in 2015.
Maria Kavallaris is an Australian scientist, based at the University of New South Wales' Children's Cancer Institute, where she is best known for her contributions to the field of cancer research. On 25 January 2019, Kavallaris was appointed a member of the Order of Australia.
Professor Susan J. Clark is an Australian biomedical researcher in epigenetics of development and cancer. She was elected a Fellow of the Australian Academy of Science in 2015, and is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow and Research Director and Head of Genomics and Epigenetics Division at the Garvan Institute of Medical Research. Clark developed the first method for bisulphite sequencing for DNA methylation analysis and used it to establish that the methylation machinery of mammalian cells is capable of both maintenance and de novo methylation at CpNpG sites and showed is inheritable. Clark's research has advanced understanding of the role of DNA methylation, non-coding RNA and microRNA in embryogenesis, reprogramming, stem cell development and cancer and has led to the identification of epigenomic biomarkers in cancer. Clark is a founding member of the International Human Epigenome Consortium (IHEC) and President of the Australian Epigenetics Alliance (AEpiA).
Georgina Venetia Long is Co-Medical Director of Melanoma Institute Australia (MIA), and Chair of Melanoma Medical Oncology and Translational Research at MIA and Royal North Shore Hospital, The University of Sydney.
Sarah Coupland is an Australian-born pathologist and professor who is the George Holt Chair in Pathology at the University of Liverpool. Coupland is an active clinical scientist whose research focuses on the molecular genetics of cancers, with particular interests in uveal melanoma, conjunctival melanoma, intraocular and ocular adnexal lymphomas and CNS lymphoma. Coupland is also an NHS Honorary Consultant Histopathologist at the Royal Liverpool University Hospital. Since 2006, Coupland has been head of the Liverpool Ocular Oncology Research Group; from which she runs a multidisciplinary oncology research group focussing on Uveal melanoma, based in the Department of Molecular and Clinical Cancer Medicine at the University of Liverpool. Her research laboratory is currently located in the Institute of Translational Medicine From April 2014 to December 2019, Coupland was also Director of the North West Cancer Research Centre, @UoL. In both 2019 and 2020, Coupland was included on the 'Pathology Powerlist' on The Pathologist website.
James Frank Bishop is an Australian doctor and the Chief Medical Officer of Australia between 2009 and 2011.
Emily Banks is an epidemiologist and public health physician, working mainly on chronic disease. She is a Professor of Epidemiology and Public Health and Head of the Centre for Public Health Data and Policy at the Australian National University, and a visiting Professor at the University of Oxford.
Leigh Ebony Boulware is an American general internist, physician-scientist, and clinical epidemiologist. She is the Eleanor Easley Professor of Medicine and director of the Clinical and Translational Science Institute at the Duke University School of Medicine.
Adeel Ajwad Butt is a Pakistani–American Infectious Diseases physician, Professor of Medicine and Population Health Sciences at the Weill-Cornell Medical College He is also the founder President and CEO of Innovations in Healthcare Advocacy, Research and Training (I-HART).
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
